PRFX (PRF Technologies) Accounts Payable: $0.18 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PRFX PRF Technologies Ltd PRFX
22 GF Score
Price $0.93
! 1 Warning Sign
View Full Analysis

What is PRF Technologies Accounts Payable?

PRF Technologies PRFX -2.38% 22 Accounts Payable is $0.18 Mil as of Jun. 2026. GuruFocus rates PRFX with a GF Score™ of 22/100. The stock has 1 warning sign investors should review.

PRF Technologies's Accounts Payable for the quarter that ended in Jun. 2026 was $0.18 Mil.

PRF Technologies's quarterly Accounts Payable increased from Jun. 2025 ($0.16 Mil) to Dec. 2025 ($0.21 Mil) but then declined from Dec. 2025 ($0.21 Mil) to Jun. 2026 ($0.18 Mil).

PRF Technologies's annual Accounts Payable increased from Dec. 2023 ($0.22 Mil) to Dec. 2024 ($0.30 Mil) but then declined from Dec. 2024 ($0.30 Mil) to Dec. 2025 ($0.21 Mil).

PRF Technologies Accounts Payable Related Terms

PRF Technologies Accounts Payable Historical Data

* Premium members only.

The historical data trend for PRF Technologies's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PRF Technologies Accounts Payable Chart

PRF Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 0.14 0.21 0.22 0.30 0.21

PRF Technologies Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.30 0.16 0.21 0.18
PRFX
22GF Score
PRF Technologies Ltd PRFX
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PRF Technologies Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.18 Mil mean?
PRF Technologies (PRFX) has a Accounts Payable of $0.18 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on PRF Technologies and its competitors.
Is PRF Technologies' Accounts Payable too high?
PRF Technologies' current Accounts Payable is $0.18 Mil. Overall, PRF Technologies has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does PRF Technologies' Accounts Payable compare to CTTH and UPC?
PRF Technologies' Accounts Payable of $0.18 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on PRF Technologies and its competitors. PRF Technologies's current Accounts Payable is $0.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PRF Technologies stock overvalued right now?
PRF Technologies (PRFX) has a current Accounts Payable of $0.18 Mil. The current Accounts Payable is $0.18 Mil. PRF Technologies' overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For PRF Technologies (PRFX), the current Accounts Payable is $0.18 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PRF Technologies Business Description

Address 65 Yigal Alon Street, Tel Aviv, ISR, 6744316
PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.
22GF Score

Get the complete analysis for PRFX

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.93
Price